Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
The following are highlights that will be in place for the 2027 plan year.
Please note: the actual drug plan options and 2027 benefits will be available for review beginning October 1, 2026.
Most drug plans will release their 2027 plan benefits to the public by late September 2026.

CMS added 15 new medications to the initial pool of 10 drugs from the 2026 cycle. Notable classes covered include cancers, respiratory, GLP-1s (diabetes/obesity). Their newly capped Maximum Fair Prices (MFPs) take effect on January 1, 2027.
More info available from CMS here
The Medicare GLP-1 Bridge Program is a short-term federal initiative running from July 1, 2026, through December 31, 2027, that gives eligible Part D beneficiaries access to specific weight-loss medications for a flat cost of $50 a month
Covered Medications
Program Costs
Basic Eligibility Requirements - to qualify, you must meet all of the following rules:
How to Get Started
More info here: https://www.medicare.gov/publications/12234-medicare-glp-1-bridge-glp-1-drugs-for-50-a-month.pdf

The Medicare prescription payment plan was introduced in 2025, and will also be available in 2027.
Copyright © 2026 Waxman Insurance - All Rights Reserved.
Not connected with or endorsed by the United States government or the federal Medicare program. We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-medicare to get information on all of your options.